Inventor · disambiguated record
Peter Serno
Also filed as: DEMBOWSKY KLAUS · SERNO PETER
20 granted patents·15 pending applications·589 citations·filing 1984–2022
96Inventor score
Top patents by PatentIndex Score
35 records- 0197US6362178B12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER AG·Filed 1998·Granted Mar 26, 2002·165 cites·8 claims
- 0295US6566360B12-phenyl substituted imidatriazinones as phosphodiesterase inhibitorsBAYER AG·Filed 2001·Granted May 20, 2003·51 cites·4 claims
- 0393US7314871B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertensionBAYER AG·Filed 2006·Granted Jan 1, 2008·18 cites·2 claims
- 0493US4957922AInfusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acidBAYER AG·Filed 1989·Granted Sep 18, 1990·95 cites·13 claims
- 0592US7696206B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2009·Granted Apr 13, 2010·12 cites·6 claims
- 0690US6890922B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER HEALTHCARE AG·Filed 2003·Granted May 10, 2005·25 cites·18 claims
- 0789US4711902AMedicament formulationBAYER AG·Filed 1984·Granted Dec 8, 1987·74 cites·24 claims
- 0887US7704999B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2007·Granted Apr 27, 2010·6 cites·9 claims
- 0983US10905667B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2018·Granted Feb 2, 2021·2 cites·25 claims
- 1079US8613950B2Pharmaceutical forms with improved pharmacokinetic propertiesSERNO PETER·Filed 2006·Granted Dec 24, 2013·11 cites·18 claims
- 1179US5653998AInjectable liposomal pharmaceutical preparationsBAYER AG·Filed 1995·Granted Aug 5, 1997·56 cites·8 claims
- 1268US2022257547A1Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2022·Application pending·0 cites
- 1366US11344519B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2020·Granted May 31, 2022·0 cites·2 claims
- 1466US9655887B2Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraceptionBayer Pharma AG·Filed 2014·Granted May 23, 2017·1 cites·19 claims
- 1566US5707655AProcess for the preparation of medicament formulations with controlled releaseBAYER AG·Filed 1996·Granted Jan 13, 1998·31 cites·9 claims
- 1666US5023257AIntramuscular injection forms of gyrase inhibitorsBAYER AG·Filed 1990·Granted Jun 11, 1991·27 cites·15 claims
- 1763US8273876B2Medicaments containing vardenafil hydrochloride trihydrateSERNO PETER·Filed 2003·Granted Sep 25, 2012·3 cites·19 claims
- 1862US6740306B2Imidazotriazinone-containing compositions for nasal administrationBAYER AG·Filed 2002·Granted May 25, 2004·3 cites·31 claims
- 1962US2013059844A12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsNIEWOEHNER ULRICH·Filed 2012·Application pending·0 cites
- 2060US2024173310A1Pharmaceutical dosage forms comprising (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoromethyl)-32h-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamideBAYER AG·Filed 2022·Application pending·0 cites
- 2156US2011009367A12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
- 2252US8841446B2Medicaments containing vardenafil hydrochloride trihydrateBAYER IP GMBH·Filed 2012·Granted Sep 23, 2014·0 cites·15 claims
- 2346US2004248891A1Imidazotriazinone-containing compositions for nasal administrationBAYER AG·Filed 2004·Application pending·0 cites
- 2445US2022117973A1The atr kinase inhibitor bay1895344 for use in the treatment of a hyper-proliferative diseaseBAYER AG·Filed 2020·Application pending·0 cites
- 2545US2021283046A1Pharmaceutical dosage form which can be administered orally and has modified releaseBAYER AG·Filed 2019·Application pending·0 cites
- 2644US2014186444A1Drug formulations having improved pharmacokinetic propertiesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2744US2009221570A1Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary HypertensionBAYER HELTHCARE AG·Filed 2006·Application pending·0 cites
- 2843US9579330B2Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraceptionBayer Pharma AG·Filed 2013·Granted Feb 28, 2017·0 cites·17 claims
- 2943US2008280914A1Intravenous Formulations of Pde InhibitorsBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3042US4976964AMedicament formulation containing dihydropyridines and a process for its preparationBAYER AG·Filed 1986·Granted Dec 11, 1990·9 cites·15 claims
- 3140US2008268046A1Formulations with Controlled Release of Active IngredientBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3240US2008187588A1Formulations With Controlled Release Of Active IngredientBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3340US2020237648A1Orally administrable modified-released pharmaceutical dosage formBAYER AG·Filed 2019·Application pending·0 cites
- 3435US2009017122A1Drug Forms Having Controlled BioavailabilityBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3530US2004142944A1Compositions for nasal applicationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Serno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →